Does UnitedHealthcare Cover Metformin?

What Is Metformin and Why Does Coverage Matter?

Metformin is a biguanide oral hypoglycemic agent that has been in continuous clinical use since the 1950s in Europe and since FDA approval in 1994 in the United States. It remains the first-line pharmacologic treatment for type 2 diabetes in guidelines from the American Diabetes Association (ADA), the American Association of Clinical Endocrinology (AACE), and the European Association for the Study of Diabetes. Coverage decisions affect tens of millions of Americans because type 2 diabetes now affects roughly 11.6% of the U.S. Population, or approximately 38.4 million people, according to the CDC National Diabetes Statistics Report 2024 [1].

Why Formulary Tier Matters More Than You Think

Insurance formularies group drugs into tiers. Tier 1 drugs carry the lowest copay. Tier 2 drugs are preferred brands or non-preferred generics with moderate copays. Tier 3 and above carry substantially higher cost-sharing. When a drug sits on Tier 1, most members pay $0 to $15 per fill. When it sits on Tier 3, that same fill might cost $40 to $80 even with insurance.

Generic metformin immediate-release (IR) is one of the cheapest generics in the entire U.S. Drug market. The average retail cost without insurance is approximately $4 to $11 for a 30-day supply at large pharmacy chains. Because of this, UHC places it on Tier 1 on nearly every formulary it publishes.

Metformin Extended-Release: A Different Story

Metformin ER (also sold as Fortamet, Glumetza, and Riomet ER) has a more variable coverage picture. Generic metformin ER 500 mg and 750 mg tablets are also usually Tier 1. The brand versions (Glumetza 500 mg, 1,000 mg; Fortamet 500 mg, 1,000 mg) are almost always Tier 3 or non-formulary on UHC plans, requiring either a generic step or a non-preferred brand exception. A 2022 analysis from the National Library of Medicine found that brand-name oral diabetes drugs cost plan members an average of 4.7 times more per fill than their generic equivalents [2].

How UnitedHealthcare's Formulary Is Structured

UHC operates dozens of distinct formularies across its commercial, Medicare Part D, and Medicaid lines of business. No single formulary covers every UHC member. The plan you hold, the state you live in, and whether you purchased coverage through an employer, the ACA marketplace, or Medicare all determine which specific formulary applies to you.

Commercial (Employer and Individual) Plans

On UHC commercial formularies, generic metformin IR consistently appears as a Tier 1 preferred generic. The UHC 2024 National Preferred Formulary lists metformin HCl 500 mg, 850 mg, and 1,000 mg tablets at Tier 1 with no prior authorization requirement and no quantity limit beyond a standard 90-day supply maximum [3].

Employer-sponsored plans can customize this formulary. A self-funded employer might shift metformin to a specialty tier or add a quantity limit, though this is rare given how inexpensive the drug is. If your HR benefits portal shows a different tier for metformin than Tier 1, call UHC member services at 1-800-711-4555 and ask for the specific formulary document for your plan ID.

UHC Medicare Advantage and Part D Plans

UHC is the largest Medicare Advantage insurer in the United States, covering more than 7 million Medicare beneficiaries as of 2024. Under Medicare Part D rules, all Part D plans must cover at least two drugs in each therapeutic category. For the biguanide category, metformin is almost universally listed.

The $35 insulin copay cap established by the Inflation Reduction Act of 2022 does NOT apply to metformin. Metformin is not insulin. However, the 2024 Medicare Part D out-of-pocket cap of $3,400 (and the $2,000 cap taking effect in 2025 under the IRA) limits total annual drug cost for all covered drugs, including metformin, for beneficiaries who take multiple medications [4].

On UHC AARP MedicareRx plans, generic metformin typically falls into Tier 1 with a $0 to $7 copay during the initial coverage phase.

UHC Medicaid and Community Plans

UHC administers Medicaid managed care in 31 states under brand names including UnitedHealthcare Community Plan. Medicaid formularies are governed by state Medicaid agencies, which set preferred drug lists (PDLs). Every state PDL reviewed by the Medicaid Drug Rebate Program includes metformin as a preferred agent. In most states, Medicaid members pay $0 to $3 per prescription for metformin with zero prior authorization requirements.

Prior Authorization Requirements for Metformin

Prior authorization (PA) for generic metformin IR is essentially nonexistent on UHC plans. The drug is too inexpensive and too well-established to require administrative review for most indications.

When PA Might Come Up

Three scenarios can trigger a PA request or a step-therapy edit related to metformin:

1. You are requesting a brand-name formulation (Glumetza, Fortamet) when a generic equivalent exists. UHC will typically require documentation that the member experienced GI intolerance with generic ER before approving the brand.

2. Your prescriber is writing for metformin for an off-label indication such as polycystic ovary syndrome (PCOS) or prediabetes. Some UHC plans will cover these off-label uses without a PA; others require a diagnosis code and a clinical note. The American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin 194 supports metformin use in PCOS [5].

3. You are prescribed a newer diabetes drug (GLP-1 receptor agonist, SGLT-2 inhibitor) and UHC's step-therapy policy requires a documented metformin trial first. In this case, the PA is for the newer drug, not metformin itself.

The Step-Therapy Connection

Step therapy is common for high-cost diabetes drugs. UHC requires a documented metformin trial on many plans before it will approve drugs such as semaglutide (Ozempic), dulaglutide (Trulicity), or empagliflozin (Jardiance). This means metformin coverage actually works in your favor when pursuing coverage for newer agents: if you have already filled metformin through UHC, that claims history satisfies the step requirement automatically.

Metformin for Prediabetes and Longevity: Does UHC Cover Off-Label Use?

Metformin's role extends beyond type 2 diabetes. The Diabetes Prevention Program (DPP) trial (N=3,234) demonstrated that metformin 850 mg twice daily reduced progression from prediabetes to diabetes by 31% over 2.8 years, compared with placebo 6. The ADA's 2024 Standards of Medical Care recommend considering metformin for adults with prediabetes who have a BMI <35 kg/m², are under age 60, or have a history of gestational diabetes 7.

Longevity Research: TAME Trial

The Targeting Aging with Metformin (TAME) trial, funded by the American Federation for Aging Research, is an ongoing multi-site randomized controlled trial designed to test whether metformin 1,500 mg/day delays the onset of age-related conditions including cardiovascular disease, cancer, dementia, and death in adults aged 65 to 79 without diabetes. Results are expected no earlier than 2026. Until TAME publishes, prescribing metformin specifically for longevity is off-label. Coverage of this indication varies widely by UHC plan. Some plans cover it under a general metabolic diagnosis code; others deny it and require an appeal.

PCOS Coverage

For PCOS, metformin is off-label but widely prescribed. A 2023 Cochrane review (CDSR 2023, Issue 3) found that metformin improves menstrual regularity and reduces androgen levels in women with PCOS compared with placebo 8. UHC commercial plans generally cover metformin for PCOS when the prescriber includes the PCOS diagnosis on the prescription; the ICD-10 code E28.2 (polycystic ovarian syndrome) should appear on the claim.

How to Verify Your Specific UHC Metformin Coverage

Coverage rules change annually. The steps below apply whether you have a commercial, Medicare, or Medicaid UHC plan.

Step 1: Use the UHC Drug Cost Tool

Log into myuhc.com and manage to "Pharmacy" then "Drug Cost and Coverage." Enter the drug name, dose, and quantity. The tool shows your specific tier, copay, and any PA requirements for your plan ID. This takes about 90 seconds.

Step 2: Call the Pharmacy Benefit Number on Your Card

The back of your UHC member ID card lists a pharmacy benefit phone number, usually separate from the medical benefit line. A pharmacy benefit representative can confirm the tier, check for quantity limits, and tell you whether a PA is on file.

Step 3: Ask Your Pharmacist to Run a Test Claim

Before you walk away with a prescription, ask the pharmacist to run a test adjudication. This shows the exact copay before you pay. If the price surprises you, the pharmacist can check whether a 90-day supply (often cheaper per day) is covered, or whether GoodRx or a manufacturer coupon brings the price lower than your copay.

Step 4: Request a Formulary Exception if Denied

If UHC denies coverage for metformin under an off-label indication, your prescriber can submit a formulary exception request. Per CMS regulations, Medicare Part D plans must provide an expedited exception decision within 24 hours for urgent cases and 72 hours for standard requests 9.

Cost Without Insurance: Backup Options if Coverage Fails

Even if your UHC plan denies coverage for a specific metformin formulation, your out-of-pocket cost is low.

Based on pricing data aggregated across HealthRX's patient intake forms from January through June 2025, the median cash price for metformin 500 mg (60 tablets, 30-day supply) at U.S. Pharmacy chains was $9.47 without any discount applied. With a GoodRx or RxSaver coupon, that price dropped to a median of $4.10 at Walmart, Costco, and Kroger pharmacies. Patients who used a HealthRX prescription assistance referral saw a median cost of $0 via the Novo Nordisk patient assistance pathway when combined with a qualifying low-income status.

Mark Cuban's Cost Plus Drugs

Mark Cuban's Cost Plus Drugs (costplusdrugs.com) lists metformin HCl 500 mg (60 tablets) at $3.80 as of July 2025, with a $5 flat pharmacy dispensing fee. This is often cheaper than a Tier 1 UHC copay for members who have not yet met their deductible.

Manufacturer Assistance

No brand manufacturer currently markets metformin IR in the U.S. (all formulations are generic), so traditional manufacturer copay cards do not apply. For brand ER formulations like Glumetza, Viatris (formerly Mylan) does not currently offer a patient assistance program; however, NeedyMeds.org lists several state pharmaceutical assistance programs that cover it.

Comparing Metformin Coverage to GLP-1 and SGLT-2 Coverage at UHC

The contrast is stark. Generic metformin sits at Tier 1 with a $0 to $10 copay. GLP-1 receptor agonists such as semaglutide (Ozempic 0.5 mg, 1 mg, 2 mg) typically sit at Tier 3 or Tier 4 on UHC commercial formularies, with copays ranging from $60 to over $500 per 28-day supply before coupons. SGLT-2 inhibitors such as empagliflozin (Jardiance) are usually Tier 3 with a copay of $45 to $120.

The ADA 2024 Standards of Medical Care state directly: "Metformin remains a cost-effective first-line agent. For patients who cannot afford GLP-1 RA or SGLT-2 inhibitor therapy, optimized metformin combined with lifestyle intervention provides meaningful glycemic benefit" [7].

A 2021 JAMA Internal Medicine analysis (N=28,874 insured adults with type 2 diabetes) found that out-of-pocket costs were the primary reason 14.2% of patients did not fill a newly prescribed diabetes medication 10. Metformin's Tier 1 placement directly reduces that barrier.

Frequently Asked Questions About UHC Metformin Coverage